Breast cancer is the most common cancer worldwide, with approximately 1.7 million new cases diagnosed each year. It is a disease that does not discriminate based on racial and ethnic groups, experiences or age. With 58 percent of deaths from breast cancer occurring in developing countries, it is also a disease that crosses international lines. In fact, breast cancer is increasing rapidly in the developing world, where cases are often diagnosed in late stages and treatment options are severely limited.
Photo courtesy of Seattle Cancer Care Alliance
Last week, we introduced you to our Innovating for a Cure series in honor of Breast Cancer Awareness Month. Today, we spotlight a pioneering medical oncologist and women’s health advocate with a powerful vision that knows no boundaries.
Dr. Julie Gralow is the director of Breast Medical Oncology at Seattle Cancer Care Alliance, and a professor in the oncology division of the University of Washington School of Medicine. She has earned numerous awards for her research, chairing several committees, and participating in expert panels for breast cancer treatment and research as a member of the Southwest Oncology Group.
But Dr. Gralow is perhaps most truly defined not by the awards she earned within labs and clinics, but by her compassion for her patients and her tireless work to empower and educate women around the world on breast cancer detection and treatment.
Taking the Fight Global
Dr. Gralow has launched an international movement of dedicated experts and volunteers arming women with the resources they need to take control of their health. She recognizes that, for far too many women around the world, fear, or the simple access to knowledge, stands in the way of early detection, treatment and ultimately, a happy ending.Read the full story »